Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Is Cencora Stock Underperforming the S&P 500?

Cencora, Inc. (COR) is a pharmaceutical sourcing and distribution company valued at a market cap of $44 billion. The Conshohocken, Pennsylvania-based company operates through the U.S. Healthcare Solutions and International Healthcare Solutions segments, providing pharmaceutical supplies, healthcare products, and services to various healthcare providers.

Companies worth $10 billion or more are generally described as "large-cap stocks," Cencora fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical distribution industry. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.